A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

105 Cites (Scopus)

Resum

Few studies have reported large inter-observer variations in target volume selection and delineation in patients treated with radiotherapy for head and neck squamous cell carcinoma. Consensus guidelines have been published for the neck nodes (see Grégoire et al., 2003, 2014), but such recommendations are lacking for primary tumour delineation. For the latter, two main schools of thoughts are prevailing, one based on geometric expansion of the Gross Tumour Volume (GTV) as promoted by DAHANCA, and the other one based on anatomical expansion of the GTV using compartmentalization of head and neck anatomy.
Idioma originalEnglish
Pàgines (de-a)206-225
Nombre de pàgines19
RevistaEuropean Journal of cancer
Volum81
DOIs
Estat de la publicacióPublicació electrònica prèvia a impressió - de juny 2017

Fingerprint

Navegar pels temes de recerca de 'A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report'. Junts formen un fingerprint únic.

Com citar-ho